Immunocytochemical profile of malignant pleural effusions of small-cell lung cancer

Minerva Medica

Volumn 93, Issue 6, 2002, Pages 479-483

  Tamiolakis, D ^a   Papadopoulos, N ^b   Cheva, A ^b   Lambropoulou, M ^a   Kotini, A ^b   Mikroulis, D ^b   Didilis, V ^b   Bitzikas, N ^b   Bougioukas, G ^b  

^a Regional Hospital of Alexandroupolis   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Carcinoma, non small cell lung; Lung neoplasms, citology; Lung neoplasms, diagnosis; Lung neoplasms, immunology; Pleural effusion

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHROMOGRANIN A; NEURON SPECIFIC ENOLASE; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CYTOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG SMALL CELL CANCER; LYMPHOID CELL; PHENOTYPE; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID; TUMOR CELL;

ANTIGENS, CD; CARCINOMA, SMALL CELL; CHROMOGRANIN A; CHROMOGRANINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHOPYRUVATE HYDRATASE; PLEURAL EFFUSION, MALIGNANT; TRANSCRIPTION FACTORS;

EID: 0037005207     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Gould VE, Linnoila RI, Memoli VA, Warren WH. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasia, and neoplasms. Lab Invest 1983;49:519-37.
2. Carter D, Yesner R. Carcinomas of the lung with neuroendocrine differentiation. Semin Diagn Pathol 1985;2:235-54.
3. Sahn SA. Malignancy metastatic to the pleural. Clin Chest Med 1998;19:351-61.
4. Bedrossian C. Malignant effusions: a multimodal approach to cytologic diagnosis. New York: Igaku-Shoin; 1994.
5. Salhadin A, Nasiell M, Nasiell K, Silfversward C, Hjerpe A, Wadas AM et al. The unique cytologic picture of oat cell carcinoma in effusions. Acta Cytol 1976;20:298-302.
6. Spriggs AI, Boddington MM. Oat-cell bronchial carcinoma. Identification of cells in pleural fluid. Acta Cytol 1976;20:525-9.
7. De May R. The art and science of cytopathology. Chicago: ASCP Press; 1996.
8. Bejarano PA, Baughman RP, Biddinger PW, Miller MA, Fenoglio-Preiser C, al-Kafaji B et al. Surfactant proteins and thyroid transcription factor-1; immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 1996;9:445-52.
9. Folpe AL, Gown AM, Lamps LW, Garcia R, Dail DH, Zarbo RJ et al. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 1999;12:5-8.
10. Di Loreto C, Di Lauro V, Puglisi F, Damante G, Fabbro G, Beltrami CA. Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol 1997;50:30-2.
11. Chhieng DC, Ko EC, Yee HT, Shultz JJ, Dorvault CC, Eltoum IA. Malignant pleural effusions due to small-cell lung carcinoma: a cytologic and immunocytochemical study. Diagn Cytopathol 2001;25:356-60.
12. Sikora J, Dworacki G, Trybus M, Batura-Gabryel H, Zermski J. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions. Tumour Biol 1998;19:196-204.
13. Tan Y, Xu M, Wang W, Zhang F, Li D, Xu X et al. IL-2 gene therapy of advanced lung cancer patients. Anticancer Res 1996;16:1993-8.
14. Miyao H, Chou T, Ito K, Moriyama H, Mitsuma S, Wakabayashi M et al. Treatment of advanced primary lung cancer associated with malignant oleural effusion by the combination of immunotherapy and chemotherapy. Oncology 1994;51:87-94.
15. Inoue Y, Shijubo N, Uede T. Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients. Jpn J Cancer Res 1990;81:1012-20.
16. Guzman J, Bross KJ, Costabel U. Malignant pleural effusions due to small cell carcinoma of the lung. An immunocytochemical cell-surface analysis of lymphocytes and tumor cells. Acta Cytol 1990;34:497-501.
17. Guzman J, Kraft A, Bross KJ, Wurtemberger G, Costabel U. Immunocytochemical characterization of malignant pleural effusions of small cell bronchial cancer. Pneumologie 1990;44Suppl. 1:601-2.
18. Sakatani M, Ogura T, Masuno T, Kishimoto S, Yamamura Y. Effect of Nocardia rubra cell wall skeleton on augmentation of cytotoxicity function in human pleural macrophages. Cancer Immunol Immunother 1987;25:119-25.
19. Bergh J, Nilson K, Cate CC, Pettengill OS, Sorenson GD. Cell surface glycoprotein patterns of cell lines derived from human small cell carcinoma of the lung. Acta Pathol Microbiol Immunol Scand [A] 1983;91:9-15.
20. Weese JL, Herberman RB, Perlin E, Mills M, Heims W, Blom J et al. Immunological monitoring and immunotherapy in carcinoma of the lung. Int J Cancer 1976;18(6):739-49.
21. Yam LT, Winkler CF. Immunocytochemical diagnosis of oat-cell carcinoma in pleural effusion. Acta Cytol 1984;28:425-9.
22. Banner BF, Warren WH, Gould VE. Cytomorphology and marker expression of malignant neuroendocrine cells in pleural effusions. Acta Cytol 1986;30:99-104.
23. Colby T, Koss M, Travis W. Atlas of tumor pathology; tumors of the lower respiratory tract. Washington, DC: Armed Forces Institute of Pathology; 1994.
24. Guinee DG jr, Fishback NF, Koss MN, Abbondanzo SL, Travis WD. The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies. Am J Clin Pathol 1994;102:406-14.
25. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB jr, Nieman L et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991;15:529-53.
26. Lazzaro D, Price M, de Felice M, Di Lauro R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991;113:1093-104.
27. Bohinski RJ, Di Lauro R, Whitsett JA. The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor-1 and hepatocyte nuclear factor-3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol 1994;14:5671-81.
28. Bohinski RJ, Huffman JA, Whitsett JA, Lattier DL. Cisactive elements controlling lung cell-specific expression of human pulmonary surfactant protein B gene. J Biol Chem 1993;268:11160-6.
29. Kelly SE, Bachurski CJ, Burhans MS, Glasser SW. Transcription of the lung-specific protein C gene mediated by thyroid transcription factor-1. J Biol Chem 1996;271:6881-8.
30. Holzinger AD, Dingle S, Bejarano PA, Miller MA, Weaver TE, DiLauro R et al. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma 1996;15:49-53.
31. Fabbro D, Di Loreto C, Stamerra O, Beltrami CA, Lonigro R, Damante G. TTF-1 gene expression in human lung tumors. Eur J Cancer 1996;32:512-7.
32. Fabbro D, Di Loreto C, Beltrami CA, Belfiore A, Di Lauro R, Damante G. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res 1994;54:4744-9.
33. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology 2000;36:8-16.
34. Kaufmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000;36:415-20.